Suppr超能文献

进行性骨化性纤维发育不良(FOP):一种骨软骨发生障碍。

Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis.

机构信息

Department of Orthopaedic Surgery, The Perelman School of Medicine of The University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Medicine, The Perelman School of Medicine of The University of Pennsylvania, Philadelphia, PA 19104, USA; The Center for Research in FOP & Related Disorders, The Perelman School of Medicine of The University of Pennsylvania, Philadelphia, PA 19104, USA.

Department of Orthopaedic Surgery, The Perelman School of Medicine of The University of Pennsylvania, Philadelphia, PA 19104, USA; The Center for Research in FOP & Related Disorders, The Perelman School of Medicine of The University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Bone. 2020 Nov;140:115539. doi: 10.1016/j.bone.2020.115539. Epub 2020 Jul 27.

Abstract

Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic disorder of extraskeletal bone formation, but could appropriately be viewed as a seminal disorder of osteochondrogenesis. Many, if not most, of the musculoskeletal features of FOP are related to dysregulated chondrogenesis including abnormal articular cartilage formation, abnormal diarthrodial joint specification, growth plate dysplasia, osteochondroma formation, heterotopic endochondral ossification (HEO), and precocious arthropathy. In FOP, causative activating mutations of Activin receptor A type I (ACVR1), a bone morphogenetic protein (BMP) type I receptor, are responsible for the osteochondrodysplasia that impacts developmental phenotypes as well as postnatal features of this illustrative disorder. Here, we highlight the myriad developmental and postnatal effects on osteochondrogenesis that emanate directly from mutant ACVR1 and dysregulated bone morphogenetic protein (BMP) signaling in FOP.

摘要

进行性骨化性纤维发育不良(FOP)是一种超罕见的骨骼外骨形成的遗传疾病,但可以被恰当地视为成骨细胞发生的主要疾病。如果不是大多数的话,FOP 的许多肌肉骨骼特征都与调控异常的软骨发生有关,包括异常的关节软骨形成、异常的关节间 specification、生长板发育不良、骨软骨瘤形成、异位软骨内骨化(HEO)和早熟性关节炎。在 FOP 中,激活素受体 A 型 I(ACVR1)的致病激活突变,一种骨形态发生蛋白(BMP)I 型受体,导致影响发育表型以及该典型疾病的产后特征的骨软骨发育不良。在这里,我们强调了源自 FOP 中突变的 ACVR1 和调控异常的骨形态发生蛋白(BMP)信号传导的直接作用对软骨内骨化的诸多发育和产后影响。

相似文献

10
Neofunction of ACVR1 in fibrodysplasia ossificans progressiva.激活素受体1型在进行性骨化性纤维发育不良中的新功能
Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15438-43. doi: 10.1073/pnas.1510540112. Epub 2015 Nov 30.

引用本文的文献

9
Fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良
Clin Case Rep. 2023 Nov 6;11(11):e8165. doi: 10.1002/ccr3.8165. eCollection 2023 Nov.
10
MicroRNA-138: an emerging regulator of skeletal development, homeostasis, and disease.微小 RNA-138:骨骼发育、稳态和疾病的新兴调节因子。
Am J Physiol Cell Physiol. 2023 Dec 1;325(6):C1387-C1400. doi: 10.1152/ajpcell.00382.2023. Epub 2023 Oct 16.

本文引用的文献

2
Hereditary multiple exostoses: are there new plausible treatment strategies?遗传性多发性骨软骨瘤:是否有新的合理治疗策略?
Expert Opin Orphan Drugs. 2018;6(6):385-391. doi: 10.1080/21678707.2018.1483232. Epub 2018 Jun 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验